Psychosis is a modern hybrid-sativa of undocumented lineage. While the specific parentage remains unknown, the strain has established a distinct presence in the cannabis market, notably influencing professional breeding projects. It is a highly productive cultivar that thrives in both indoor and outdoor environments, requiring a moderate level of grower expertise to reach its potential. Those cultivating the plant should expect a flowering cycle of approximately 63 days, after which the plants typically yield high quantities of finished flower.

The aromatic profile of Psychosis is defined by a terpene composition dominated by terpinolene, followed in intensity by myrcene and caryophyllene. This specific chemical hierarchy creates a distinct sensory experience, blending the sharp, floral notes of the primary terpene with the earthy, herbaceous undertones provided by the secondary and tertiary compounds. Users will encounter these profiles upon both inhalation and consumption, providing a consistent organoleptic experience that highlights its hybrid-sativa classification.

In terms of effects, Psychosis is a THC-dominant cultivar known for producing sensations of euphoria, upliftment, and heightened creativity. Because of these characteristics, it is often utilized in scenarios where focus and social engagement are required, as the effects facilitate an active, clear-headed state. The genetic legacy of this strain is evidenced by its notable offspring, which include Psychosis BX1, Psychosis x Blues, and the well-documented UK Psychosis.